文献速递流行病学与生物统计组学、生物样本库与精准医学基础与转化研究

血钙正常人群血钙升高遗传倾向与骨密度及骨折风险的孟德尔随机化研究

Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study.
PubMed 文献 · BMJ · 2019-08-01

该孟德尔随机化研究利用61 079人的全基因组关联荟萃分析识别血钙遗传决定因素,在426 824名平均血钙正常者中评估遗传预测血钙升高与跟骨超声骨密度的关联,并在76 549例骨折病例和470 164名对照中分析骨折风险。结果显示遗传预测血钙每升高1个标准差(0.13 mmol/L或0.51 mg/dL)与估计骨密度升高及骨折风险降低均无关联。

要点

  • 遗传预测血钙每升高1个标准差(0.13 mmol/L或0.51 mg/dL)与估计骨密度无关联(0.003 g/cm2,95%CI -0.059至0.066;P=0.92)。
  • 遗传预测血钙升高与骨折风险无关联(OR 1.01,95%CI 0.89至1.15;P=0.85)。
  • 在血钙正常人群中,遗传倾向血钙升高不提供有临床意义的骨折保护。

核心结论

  • 在血钙正常人群中,遗传倾向血钙升高与估计骨密度升高及骨折风险降低均无关联。
  • 遗传倾向血钙升高是否模拟短期补钙效果尚不清楚。
  • 鉴于相同的遗传预测血钙升高与冠状动脉疾病风险增加相关,在一般人群中广泛补钙可能弊大于利。

研究设计与样本

  • 孟德尔随机化研究。
  • 利用最多61 079人的血钙全基因组关联荟萃分析识别血钙遗传决定因素。
  • 使用英国生物银行426 824名平均血钙正常者的跟骨超声数据评估遗传预测血钙与估计骨密度的关联。
  • 骨折全基因组关联荟萃分析包含24个队列及英国生物银行,共76 549例骨折病例和470 164名对照,平均血钙亦正常。

主要发现

  • 遗传预测血钙每升高1个标准差(0.13 mmol/L或0.51 mg/dL)与估计骨密度升高无关联(0.003 g/cm2,95%CI -0.059至0.066;P=0.92)。
  • 遗传预测血钙每升高1个标准差与骨折风险降低无关联(OR 1.01,95%CI 0.89至1.15;P=0.85)。
  • 逆方差加权孟德尔随机化分析的敏感性分析未提供多效性证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if genetically increased serum calcium levels are associated with improved bone mineral density and a reduction in osteoporotic fractures. DESIGN: Mendelian randomisation study. SETTING: Cohorts used included: the UK Biobank cohort, providing genotypic and estimated bone mineral density data; 25 cohorts from UK, USA, Europe, and China, providing genotypic and fracture data; and 17 cohorts from Europe, providing genotypic and serum calcium data (summary level statistics). PARTICIPANTS: A genome-wide association meta-analysis of serum calcium levels in up to 61 079 individuals was used to identify genetic determinants of serum calcium levels. The UK Biobank study was used to assess the association of genetic predisposition to increased serum calcium with estimated bone mineral density derived from heel ultrasound in 426 824 individuals who had, on average, calcium levels in the normal range. A fracture genome-wide association meta-analysis comprising 24 cohorts and the UK Biobank including a total of 76 549 cases and 470 164 controls, who, on average, also had calcium levels in the normal range was then performed. RESULTS: A standard deviation increase in genetically derived serum calcium (0.13 mmol/L or 0.51 mg/dL) was not associated with increased estimated bone mineral density (0.003 g/cm2, 95% confidence interval -0.059 to 0.066; P=0.92) or a reduced risk of fractures (odds ratio 1.01, 95% confidence interval 0.89 to 1.15; P=0.85) in inverse-variance weighted mendelian randomisation analyses. Sensitivity analyses did not provide evidence of pleiotropic effects. CONCLUSIONS: Genetic predisposition to increased serum calcium levels in individuals with normal calcium levels is not associated with an increase in estimated bone mineral density and does not provide clinically relevant protection against fracture. Whether such predisposition mimics the effect of short term calcium supplementation is not known. Given that the same genetically derived increase in serum calcium is associated with an increased risk of coronary artery disease, widespread calcium supplementation in the general population could provide more risk than benefit.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Cerani A, Zhou S, Forgetta V, et al. Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study. BMJ. 2019. PMID: 31371314. doi:10.1136/bmj.l4410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。